fda bpc-157 warning letter or statement to Neil R. Feins, M.D. 2009-05-20 Multifunctionality and Possible Medical Application

Multifunctionality and Possible Medical Application of the BPC 157 PeptideLiterature and Patent Review An FDA advisory committee voted Thursday to remove compounding restrictions on four peptides despite little evidence the products are safe or effective for medical use. In a series of 8 6 votes (with FDA issued 25 warning letters to telehealth companies for false and misleading claims about compounded GLP 1 products. Unlike FDA approved drugs, these products have not been proven to be safe, effective, or of FDA takes first step in possible reversal of ban on some peptides The Washington Post

SKU: 42324620447 · From www.marsberger-treibhaus.de